Anna Navarro Figueredo^1*, Daniele Scarcella, MSc^2*, Michele C Buck, MSc^1*, Maximilian Buser, PhD^2*, Jennifer Rivière, PhD^1*, Michael Sterr, PhD^3*, Wencke Walter, PhD⁴, Priyansh Srivastava, MSc^5,6*, Judith S. Hecker, MD^1*, Ana Conesa, PhD^5,6*, Mark van der Garde, PhD^1*, Carsten Marr, PhD^7,8* and Katharina S. Götze, MD⁹

¹Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
²Institute of AI for Health, Helmholtz Zentrum Munich - German Research Center for Environmental Health, Neuherberg, Germany
³Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany
⁴Munich Leukemia Laboratory, Munich, Germany
⁵BioBam Bioinformatics S.L., Valencia, Spain
⁶Institute for Integrative Systems Biology (CSIC-UV), Spanish National Research Council, Valencia, Spain
⁷Institute of AI for Health, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
⁸Helmholtz AI, Helmholtz Zentrum Munich - German Research Center for Environmental Health, Neuherberg, Germany
⁹Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany

Troy Lund, MD, PhD, MS, Paul Orchard, MD^* and Ashish O. Gupta, MBBS, MPH

University of Minnesota, Minneapolis, MN

Anastasia N. Tikhonova, PhD¹, Ximing Li, BS², Alicia Aguilar-Navarro^3*, Mursal Nader^4*, Gibran Edun, BS^3*, Mark Gower, PhD³, Soheil Jahangiri, PhD^1*, Ho Seok Lee, BS^3*, David-Michael Phillips^5*, Minerva Fernandez, MSc^3*, Pirakashini Ramkumar^3*, Daniel Coutu^6*, Cari Whyne^7*, Gregory Schwartz, PhD^3*, Thomas Kislinger, PhD^1* and Margarete Akens^3*

¹Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²University of Toronto, Toronto, ON, CAN
³University Health Network, Toronto, ON, Canada
⁴University Health Network, Toronto, ON, CAN
⁵Sunny Brook Health Center, Toronto, Canada
⁶Ottawa Hospital Research Institute, Ottawa, Canada
⁷Sunnybrook Research Institute, Toronto, ON, Canada

Gamze Gürsoy^1*, Asuman Sunguroğlu, Prof. Dr.^2*, Tuba Özdemir Sancı, PhD.^3*, Yasin Köksal^4*, Doğa Tezal^5*, Hüsniye Neşe Yaralı, Prof. Dr.^6*, İrem Kar^7*, Dilek Kaçar, MD^8*, İkbal Ok Bozkaya, MD.^9*, Özlem Arman Bilir, MD^9*, Şerife Mehtap Kanbur, MD^10*, Emin Kansu, MD¹¹, Meltem Özgüner, Prof. Dr.^3* and Namık Yaşar Özbek, Prof. Dr.^9*

¹Child Health and Diseases, Hospital, Ankara, Turkey
²Medical Biology, Ankara University, Ankara, Turkey
³Department of Histology and Embryology, Ankara Yıldırım Beyazıt University, Ankara, Turkey
⁴Stem Cell Research Laboratory, Bilkent City Hospital, Ankara, Turkey
⁵Department of Medical Biology, Ankara University, ankara, Turkey
⁶Child Health and Diseases, Pediatric Hematology and Oncology, Ankara, Ankara, TUR
⁷Department of Biostatistics, Ankara University, Ankara, Turkey
⁸Child Health and Diseases, Pediatric Hematology and Oncology, Bilkent City Hospital, Cankaya, Turkey
⁹Child Health and Diseases, Pediatric Hematology and Oncology, Bilkent City Hospital, Ankara, Turkey
¹⁰Child Health and Diseases, Bilkent City Hospital, Cankaya, Turkey
¹¹Hacettepe University Cancer Institute, ANKARA-TURKEY, TUR

Pengju Gong, MBBS, MS¹, Yamei Chen, PhD^2*, Leng Han, PhD^3*, Liuqing Yang, PhD^4* and Chunru Lin, MD, PhD¹

¹Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
²School of Medicine, Indiana University, Indianapolis
³School of Medicine, Indiana University, Indianapolis, IN
⁴Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston

Christopher P. Ly, MS^1*, Ivo Veletic, MD^2*, Christopher D. Pacheco, BS^1*, Enes Dasdemir, BS^1*, Fatima Z Jelloul^3*, Sammy Ferri-Borgogno, PhD^4*, Akshay Basi^1*, Javier A. Gomez^1*, Jessica Lynn Root, MS^5*, Patrick K. Reville, MD, MPH¹, Andres E Quesada, MD^6*, Carlos E. Bueso-Ramos, MD, PhD⁷, Miriam B. Garcia, DO^8*, Jared K. Burks, PhD^1* and Hussein A. Abbas, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴University of Texas, MD Anderson Cancer Center, Houston
⁵Department of Leukemia, The University of Texas MD Anderson Cancer center, Houston, TX
⁶Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Division of Pediatrics, MD Anderson Cancer Center, Houston, TX

Kristina Mott^1*, Margret Droste^2*, Maria Drayss, MD^2,3*, Lukas Johannes Weiss, MD^2,3*, Zoltan Nagy, PhD^2* and Harald Schulze, PhD²

¹Institute for Experimental Biomedicine, University Hospital Würzburg, WüRzburg, Germany
²Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany
³Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany

Mélanie Gadelorge, PhD^1*, Caroline Siekaniec^1*, Maria De Grandis, PhD^2*, Frederic Deschaseaux, PhD^1*, Jean-Gerard Descamps^1*, Cécile Dromard, PhD^1*, Wassim El Nemer, PhD³, Marie Salon, PhD^1*, Victorine Douin-Echinard, PhD^1*, Agnes Coste, PhD^1* and Nicolas Espagnolle, PhD^4*

¹Geroscience and rejuvenation research center (RESTORE), INSERM 1301, UMR CNRS 5070, Univ. P. Sabatier, EFS / ENVT, Toulouse, France
²EFS PACA-Corse, Aix Marseille University, UMR 7268 ADES, Marseille, France
³Établissement Français du Sang PACA-Corse, Aix Marseille Université, CNRS, UMR 7268 ADES, Marseille, France
⁴Geroscience and rejuvenation research center (RESTORE), INSERM 1301, UMR CNRS 5070, Univ. P. Sabatier, EFS / ENVT, TOULOUSE, FRA

Zhenkun Wang^1*, Zhi-Wei Zhang^1*, Zhong-Shi Lyu, PhD^1*, Tong Xing^1*, Mi Liang^1*, Mengzhu Shen, PhD^1*, Chen-Yuan Li^1*, Xin-Yan Zhang, MS^1*, Dan-Dan Chen^1*, Ya-Zhe Wang^1*, Li-Juan Hu^2*, Hao Jiang^3*, Qian Jiang, MD⁴, Yuan Kong, MD, PhD^1* and Xiao-Jun Huang, MD¹

¹Peking University People’s Hospital, Beijing, China
²Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
³Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁴National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China

Xuan Cai^1*, Jin Wu, MD^1*, Haixia Fu, MD^2* and Xiao-Hui Zhang, MD, PhD³

¹Peking University People's Hospital, Beijing, CHN
²Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China., Beijing, China
³Peking University People’s Hospital, Beijing, China